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Prior to Fontan: A Comparison of 3 Groups
Pre-Fontan CMR Versus Cath Evaluation
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Matthew A. Harris, MD,*† Marc S. Keller, MD,† Andrew C. Glatz, MD,* Winnie Zhu, PHD,†
David Shore, BS,* Laura K. Diaz, MD,‡ Jonathan J. Rome, MD*
Philadelphia, Pennsylvania
Objectives This study investigated whether cardiac magnetic resonance (CMR) and echocardiography (echo) can replace
catheterization (cath) for routine evaluation prior to Fontan and under what circumstances CMR and cath are
used together.
Background Routine cath prior to Fontan has been utilized for years; noninvasive methods, however, may be sufficient.
Methods This study reviews clinical data in 119 consecutive patients investigating 3 groups: those who underwent CMR
alone (MR; n  41), cath alone (C; n  41), or both cath and CMR (CM; n  37) prior to Fontan.
Results No clinically significant differences were noted in patient characteristics, hemodynamics, or clinical status prior
to or after surgery between the C and MR groups. CMR added information in 82%. There were no discrepant
findings between CMR and cath data in the CM group. Diagnostic success was 95% in all groups. Of those
undergoing Fontan completion, the CM group had similar outcomes to C and MR; C and CMR were utilized in
combination to assess aortopulmonary collaterals or the need for an intervention or evaluate its success. Echo
could not delineate pulmonary arterial anatomy in 46% to 53% of patients. The CM and C groups were ex-
posed to 6.8  4.1 mSv of radiation.
Conclusions Single ventricle patients not requiring an intervention can undergo successful Fontan completion with CMR and
echo alone with similar short-term outcomes to C, which was used as a control, preventing an invasive test and
exposure to radiation. CMR can add information in a significant number of patients. Cath and CMR are utilized
together for interventions and assessment of aortopulmonary collaterals. (J Am Coll Cardiol 2012;60:
1094–1102) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.06.021Improved outcomes for functional single ventricle patients
undergoing Fontan completion (1,2) are due in part to
preoperative imaging that identifies multiple parameters
correlated with postoperative outcomes (3–7). Routine eval-
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accepted June 26, 2012.uation has included echocardiography (echo) and cardiac
catheterization (cath); however, both have shortcomings.
Poor acoustic windows may limit visualization of cardiovas-
cular structures (8) and the lack of quantitative single
ventricle functional and flow assessment are limitations of
echo. Cath is inherently an invasive, 2-dimensional modal-
ity associated with a small but significant morbidity and
utilizes ionizing radiation that may increase cancer risk
(9–11). In select groups of single ventricle patients, nonin-
vasive imaging modalities may suffice (8,12–14). Ro et al.
developed a set of criteria to determine the need for cath
prior to Fontan based mainly on echo data, hemoglobin,
and pulse oximetry (8). Their criteria were developed in
order to identify all patients who died or required additional
cath interventions. The criteria in that study had a negative
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September 18, 2012:1094–1102 Pre-Fontan CMR Versus Cath Evaluationpredictive valve of 93%; the positive predictive value (52%) and
sensitivity (25%), however, were poor, primarily due to unsuc-
cessful imaging of the pulmonary arteries (PAs) resulting from
poor acoustic windows. They suggested that cardiac magnetic
resonance (CMR) may have helped.
CMR, successfully used for years to assess single ventricle
patients (15), is an excellent noninvasive tool for assessing cardio-
vascular anatomy (16,17), ventricular function (18–20), and blood
flow. CMR obtains data unavailable to other modalities, such as
assessment of aortopulmonary collateral flow which imposes a
volume load on the ventricle, even in the hemi-Fontan/
bidirectional Glenn stage (21).
We hypothesized that in a group of routine pre-Fontan
atients, CMR and echo alone provide sufficient pre-
perative evaluation to allow successful Fontan completion.
he purpose of this study is to test this hypothesis by
omparing short-term outcomes and accuracy of diagnostic
esting in 3 groups: patients undergoing CMR and echo
lone (MR); cath and echo (C); and CMR, cath, and echo
CM). The MR group was the test group while the C
roup was used as a control. We also sought to determine in
hat instances all 3 modalities are used in pre-operative
valuation (CM group). Finally, we tested the hypothesis
hat the addition of CMR to echocardiographic imaging in
he Ro criteria would successfully identify patients who may
ot require cardiac catheterization prior to Fontan comple-
ion. Preoperative demographics and hemodynamics were
nalyzed in each group to demonstrate comparability for
perative risk.
ethods
atients. A search of CMR and cath databases was per-
ormed for all single ventricle patients prior to Fontan
ompletion between January 2005 and October 2009. Three
roups were identified: 1) patients with CM; 2) patients
ith only CMR; and 3) patients with only C. All patients
ho underwent CMR were enrolled while a set of consec-
tive C patients picked at random during the study period
ere identified equal in number to the CMR group for
omparability. For CM, studies were performed within a
ear of each other; no clinical changes were noted in
etween studies.
CMR ProtocolTable 1 CMR Protocol
Section of Exam Technique
1 Contiguous, axial static SSFP, and HASTE images
2 Cine SSFP images of “3 chamber” and stack of contiguous
3 Cine SSFP images of BPAs and SVC to PA anastomosis, ve
cane view of the aorta
4 Phase-encoded velocity mapping of the cavae, BPAs, semi
5 3-Dimensional gadolinium imaging
6 ViabilityBPA  branch pulmonary artery; CMR  cardiac magnetic resonance; HASTE  half Fourier acquisition
superior vena cava.CMR protocol. CMR was per-
formed on a Siemens 1.5-T Sonata
or Avanto MRI system (Siemens
Medical Solutions, Malvern, Penn-
sylvania) with data analyzed using
the standard Siemens’ analysis pack-
age. The CMR protocol is listed in
Table 1.
Cath protocol. Routine pre-
Fontan cath was performed as per
protocol. Hemodynamic measure-
ments (pressures and oxygen satura-
tion) were obtained in the atria, ven-
tricle(s), PAs, and aorta followed by
angiography of the ventricle, aortic
arch, and PAs. Interventions were
performed as determined by the
physician performing the cathe-
terization.
Echo protocol. A standard pe-
diatric echo was performed as
delineated in the guidelines of
Lai et al. (22). Two-dimensional,
Doppler, and color flow mapping
of the relevant cardiovascular
structures included evaluation of single ventricle anatomy
and function, atrioventricular valve regurgitation (AVVR),
PA and superior vena cava (SVC) to PA anastomosis,
ventricular outflow tract, and aorta.
Data abstraction. All CMR, cath, and echo data were
reviewed. CMR data included ventricular volumes and
mass, ventricular performance parameters, and anatomic
data with quantitative measures of cardiovascular structures.
Cath data included hemodynamic measurements and ana-
tomic findings with quantitative measures of cardiovascular
structures; calculated data (systemic and pulmonary blood
flow and pulmonary vascular resistance [PVR]) were also
noted. Anatomic findings for both CMR and cath included
assessment of SVC to right pulmonary artery (RPA) anas-
tomosis, PAs, pulmonary venous anatomy, ventricular out-
flow tract obstruction, aortic assessment including coarcta-
tion, presence of a left SVC, decompressing vessel, or other
venous anomalies. Self-reported serious complications from
Abbreviations
and Acronyms
AVVR  atrioventricular
valve regurgitation
C  catheterization and
echocardiography alone
CM  cardiac
catheterization and cardiac
magnetic resonance
cath  catheterization
CMR  cardiac magnetic
resonance
echo  echocardiography
ICU  intensive care unit
LPA  left pulmonary
artery
MR  cardiac magnetic
resonance and
echocardiography alone
PA  pulmonary artery
PVR  pulmonary vascular
resistance
SVC  superior vena cava
Purpose
Survey cardiovascular anatomy
axis images Assess ventricular volumes, mass, and function
ar outflow tract, and candy Assess anatomy
alves, and pulmonary veins Assess flows
Assess anatomy
Myocardial scarringsingle shot turbo spin echo; PA  pulmonary artery; SSFPshort
ntricul
lunar v steady-state free precession; SVC 
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Pre-Fontan CMR Versus Cath Evaluation September 18, 2012:1094–1102CMR and cath (e.g., days in the intensive care unit [ICU])
were recorded. Echos were examined to determine if each
provided a comprehensive evaluation, with a primary crite-
rion of whether the PAs were visualized. Surgical and
hospital reports were evaluated for type of fenestrated
Fontan (lateral tunnel or extracardiac), bypass time, circu-
latory arrest time, surgical findings, complications, ICU
days, and the length of hospital stay. Reviews of CMR,
cath, surgical reports, and clinical outcome were all blinded
to the other’s test results. Ro criteria were applied to these
patients, stating that any of the following findings indicated
a need for cath: 1) left pulmonary artery (LPA) not
visualized or stenotic; 2) significant AVVR; 3) significantly
diminished ventricular contractility; 4) aortic coarctation;
5) restrictive atrial septal defect; or 6) evidence of a
decompressing vessel. For this study, by CMR, a stenotic
branch PA was defined as 25% of the total cross-sectional
area of the branch PA (7); significant AVVR was defined as
20% regurgitant fraction (moderate regurgitation); dimin-
ished ventricular contractility was defined as ejection frac-
tion 45%; aortic coarctation was defined as narrowing
ith a gradient; and restrictive atrial septal defect was
efined as a small defect with turbulence noted. By echo,
hese were all assessed qualitatively.
ffective radiation dose. A total effective radiation dose
(mSv) for each cath was estimated based on a conversion of
the dose-area product (Gy·m2) using the Monte Carlo
method. A straight frontal projection angle was assumed.
Using data collected from our current system with available
fluoroscopy time and measured dose-area product for each
case, a series of best-fitting lines from linear regression was
generated for a variety of different weight categories. Using
the equation for the best-fitting line for the 5 to 15 kg
weight category, we converted fluoroscopy time to dose-area
product for the older cases, then converted the dose-area
product to mSv dose.
Statistics. Descriptive statistics were used, recorded as
mean  SD. Pairwise comparisons were made using an
npaired Student t test. An analysis of variance was used to
ompare all 3 groups for surgical and clinical outcomes.
iagnostic success rates were calculated for each group by
omparing preoperative diagnoses with surgical findings. In
M, diagnostic success rate between CMR and cath was
lso calculated. In CM, only patients who had a com-
leted Fontan within the study date range were included in
he statistical analysis for outcomes. To compare categorical
ata (intervention in each cath group), Fisher exact and
hi-square tests were used where applicable. A p value
0.05 was considered significant.
esults
tudy population. The study comprised 119 pre-Fontan
atients. Of those, 78 consecutive patients were referred to
MR, 37 in CM and 41 in MR. Of 246 patientsvaluated by cath in this time frame, 41 consecutive patients
P
tere in C. All patients in the C and MR groups completed
he Fontan, however, in the CM group, 6 patients had not
ompleted the Fontan (2 died unrelated to cath or CMR, 1
nderwent heart transplantation, and 3 are awaiting com-
letion). Those who did not undergo Fontan in CM are
ot included in outcomes data (as, for example, length of
tay after a Fontan would not apply) or hemodynamics
which is meant to demonstrate comparability prior to
ontan as it relates to quantitative outcome data) but are
ncluded for comparison between cath and CMR findings
or accuracy of CMR (validating CMR vs. cath) as well as
isposition of patients in CM group (determining when
MR and cath can be utilized together in patient manage-
ent). Both patients who died had chronic respiratory/lung
isorders and the 1 who underwent heart transplantation
ad moderate ventricular dysfunction (end-diastolic volume
f 187 cc/m2 and an ejection fraction of 33% by CMR).
Patient demographics are described in Table 2. Patients fell
into each group depending on whether the referring cardi-
ologist felt they required an intervention at cath or had a
practitioner bias toward either cath or CMR prior to Fontan
(comparability between all 3 groups is discussed subse-
quently). The number of patients in each group are listed in
Table 3.
Noninvasive imaging. PAs were visualized by echo in 51%
of patients in the CM group, 46% in the MR group, and
54% in the C group (p  0.73).
The addition of CMR added significant clinical informa-
tion in 64 (82%) of the patients who underwent that test
Study Population CharacteristicsTable 2 Study Population Characteristics
CM CMR Only Cath Only
Patients (N) 37 41 41
Sex (male/female) 23/14 21/20 21/20
Age at SCPC, yrs 0.52 0.24 0.47 0.13 0.43 0.11
Dominant, functional, single RV 27 24* 33*
DORV 5 2 7
HLHS 16 20 24
RV Aorta with PA 4 0 0
Unbalanced AVC to RV 2 2 2
Dominant, functional, single LV 9 17* 8*
DILV 1 4 3
DORV 0 0 1
PA/severe PS with hypoplastic RV 2 2 2
TA 6 9 2
TGA 0 2 0
Indeterminate ventricular morphology 1 0 0
SCPC type 37 41 41
BDG (bilateral BDG) 28 (4) 31 (2) 26 (4)
Hemi-Fontan (left hemi-Fontan) 6 (1) 8 15
Kawashima 3 2 0
Values are mean  SD. *Not significantly different (p  0.08).
AVC  atrioventricular canal; BDG  bidirectional Glenn; CM  cardiac catheterization and
ardiac magnetic resonance; DILV  double inlet left ventricle; DORV  double outlet right
ventricle; HLHS  hypoplastic left heart syndrome; LV  left ventricle; PA  pulmonary atresia;
S pulmonary stenosis; RV right ventricle; SCPC superior cavopulmonary connection; TA
ricuspid atresia; TGA  transposition of the great arteries.
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September 18, 2012:1094–1102 Pre-Fontan CMR Versus Cath Evaluation(Fig. 1). Echo identified 7 patients with a normal LPA, later
discovered by CMR to be hypoplastic/stenotic; in 8 others,
the LPA, described as hypoplastic/stenotic by echo, was
subsequently found to be normal on CMR. One patient
described by echo with no AVVR had significant AVVR on
CMR, whereas 1 patient had AVVR described as moderate
by echo but quantitatively had minimal AVVR on CMR.
For structures not visualized on echo, CMR identified 8
patients with LPA hypoplasia/stenosis, 9 patients with
normal LPA, and 13 with some form of decompressing
vessels. The addition of CMR enabled characterizing the
LPA and decompressing vessels in 5 with incomplete/
absent echo studies, quantification of collateral flow in 13,
RPA stenosis or hypoplasia in 3, and delineation of pulmo-
nary venous anatomy in 2. Five patients had 2 findings and
1 patient had 3 findings (70 findings in 64 patients). To
summarize, the discrepancies between echo and CMR were
largely extracardiac vascular anatomy (PAs, pulmonary
veins, decompressing vessels and collaterals) with 2 differ-
ences in assessment of AVVR regurgitation.
Only 1 complication was noted in the MR group
(endotracheal tube becoming obstructed because of se-
cretions).
Cardiac catheterization. DISPOSITION OF CM PATIENTS.
Of the 37 patients, 4 were referred for intervention at cath
prior to CMR; 2 underwent an intervention and CMR was
performed to evaluate the result. In the 2 who did not
undergo intervention, cath was truncated and CMR was
utilized to perform a full evaluation. Thirty-three under-
went CMR prior to cath, and 11 eventually had an inter-
vention. Of the remaining patients, 20 met Ro criteria for
cath (12 by CMR and echo and 8 by CMR alone); 2 met Ro
criteria to avoid cath by CMR alone but proceeded to cath
despite the negative CMR results because of practitioner
bias for cath prior to Fontan (Table 3, Fig. 2).
C ONLY PATIENTS. Of the 41 patients, 6 (15%) underwent
Numbers of Patients in Each Groupand R as n for E ry Into GroupTable 3 Numbe s of Patients in Each Groupand Reason for Entry Into Group
CM
Cath
Only
CMR
Only
Patients 37 41 41
Cath  CMR (intervention) 2* N/A N/A
Cath  CMR (no intervention) 2 N/A N/A
CMR  cath (intervention) 11* N/A N/A
CMR  cath (no intervention), diagnostic cath† 22‡ N/A N/A
Interventional cath only N/A 6* N/A
Routine diagnostic cath§ N/A 35 N/A
Cath not needed: routine CMR prior to Fontan N/A N/A 41
*Interventions included coiling aortic to pulmonary collaterals, coiling of atrial to systemic venous
decompressing vessel, radiofrequency ablation for arrhythmia, angioplasty  stent placement in
ranch pulmonary artery. †20met Ro criteria, 2 without Ro criteria but progressed to cath because
f physician referral bias. ‡Included 4 patients with cardiac magnetic resonance (CMR) to quantify
ortic to pulmonary artery collateral flow. §“Routine” implies that the referring cardiologist viewed
his test as part of usual approach to single ventricle patient prior to Fontan.
Cath  catheterization; Cath  CMR  catheterization occurred after CMR; Cath  CMR 
atheterization occurred prior to CMR; N/A  not applicable.n intervention (2 identified by echo prior to cath, 3 notdentified by echo, and 1 ablation). The other 35 patients
nderwent “routine” cath prior to Fontan because of prac-
itioner bias for cath prior to Fontan.
COMPLICATIONS. In CM, no complications were noted,
while in C, 3 complications were present (2 patients with
complete heart block (1 required chest compressions and
atropine) and 1 with inadvertent entry into the right carotid
artery). The number of days in the ICU after cath are shown
in Table 4 (range 0 to 1 days in C and 0 to 2 days in CM).
RADIATION EXPOSURE. In the CM and C groups, radia-
ion dose estimate was 6.8  4.1 mSv with a range of 2.1 to
7.9 mSv.
he Ro criteria and predictive values. Of the 78 CMRs
erformed, 47 Ro criteria were changed in 43 (55%)
atients; 3 patients had multiple criteria changed. Of the 43
atients whose Ro criteria changed with CMR, 31 (72%)
voided catheterization, usually as a result of delineation of
ulmonary arterial anatomy or decompressing vessels (in 30
f 31 patients). Twenty-three percent (n  10) were
dentified with indications for catheterization that had not
een identified by echo (usually the presence of a stenotic
ulmonary artery). Two patients (5%) went to cath despite
he negative Ro criteria because of physician referral bias for
ath. In addition, CMR added information that did not
hange the Ro criteria in 21 (27%) additional patients (see
oninvasive Imaging subsection and Fig. 2). In summary,
Figure 1 CMR Imaging of Single Ventricle Patients
Prior to Fontan
(A) Steady-state free precession cine in a 3-chamber (left) and short-axis view
(right) of a patient with hypoplastic left heart syndrome. (B) Three-dimensional
gadolinium images of the patient in A from anterior (left) and posterior (right)
angles demonstrating the aortopulmonary anastomosis (Ao-PA), the superior
vena cava to right pulmonary artery anastomosis (SVC-RPA) of a bidirectional
Glenn, and the branch pulmonary artery. CMR  cardiac magnetic resonance;
DAo  descending aorta; RA  right atrium; RV  right ventricle.
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mation in 64 (82%) of patients.
By utilizing the patients in the CM group, the positive
and negative predictive values of echo and CMR including
the Ro criteria to determine findings or interventions at cath
were each 100%. The C group alone was used to determine
these parameters for the sole use of echo prior to cath
Figure 2 Disposition of CM Patients
The flow diagram demonstrates the disposition of the 37 CM patients, focusing
CMR  Cath indicates that CMR occurred prior to cath while CMR  Cath indicate
as balloon angioplasty or coil embolization. In the rightmost balloons, Ro or Ro-
alone; CMR or CMR- refers to the patient meeting or not meeting the Ro criteria
catheterization and cardiac magnetic resonance; CMR  cardiac magnetic resona
Cardiac Catheterization DataTable 4 Cardiac Catheterization Data
C
Age at cath, yrs 2.58 1.11 (n
Years from cath to Fontan 0.44 0.61 (n
Height, cm 85.8 8.60 (n
Weight, kg 12.9 2.32 (n
BSA at cath, m2 0.54 0.11 (n
Interventions 8
RPA mean, mm Hg 12.7 3.5 (n 2
LPA mean, mm Hg 12.8 3.7 (n 2
SVC mean, mm Hg 12.7 3.6 (n 2
Ventricular systolic pressure, mm Hg 90.4 14.8 (n
Ventricular diastolic pressure, mm Hg 6.3 4.4 (n 3
Qs, l/min/m
2 3.46 1.01 (n
Qp, l/min/m
2 2.33 0.51 (n
PVR, Woods units 1.68 0.63 (n
Hemoglobin, mg/dl 16.4 1.66 (n
O2 Sat, (%) 80.4 4.41 (n
Days in ICU after cath 0.12 0.5 (rang
Values are mean  SD.
BSA  body surface area; Cath  catheterization; CM  cardiac cLPA  left pulmonary artery; O2 sat  arterial blood oxygen saturation; P
Qs  systemic blood flow; RPA  right pulmonary artery; SVC  superiorutilizing the Ro criteria; the positive and negative predictive
values were 25% and 85%, respectively.
Perioperative outcomes. COMPARISON BETWEEN GROUPS
N PRE-OPERATIVE EVALUATION. To assess pre-operative
clinical status in each group and demonstrate comparability
of risk for Fontan completion, cath data from CM and C
are shown in Table 4 and CMR data from CM and MR
ether they met Ro criteria and the reasons for the combination of cath and CMR.
occurred after cath. Intervention stands for a catheterization intervention such
to the patient meeting or not meeting the Ro criteria, respectively, utilizing echo
ctively, utilizing CMR as well as echo. Cath  catheterization; CM  cardiac
cho  echocardiography.
Cath Only p Value
2.64 0.64 (n 41) 0.31
0.12 0.20 (n 41) 0.01
87.8 5.47 (n 41) 0.44
12.6 1.79 (n 41) 0.38
0.54 0.05 (n 41) 0.25
6 0.45
11.2 2.44 (n 37) 0.08
11.2 2.43 (n 39) 0.06
11.5 2.45 (n 39) 0.08
87.0 10.7 (n 40) 0.09
6.18 3.70 (n 40) 0.46
4.14 1.02 (n 41) 0.02
2.56 0.53 (n 41) 0.04
1.54 0.52 (n 41) 0.27
16.0 1.31 (n 41) 0.50
81.5 4.34 (n 41) 0.45
(n 31) 0.02 0.16 (range 0–1) (n 41) 0.10
ization and cardiac magnetic resonance; ICU  intensive care unit;on wh
s CMR
refers
, respe
nce; eM
31)
31)
31)
31)
31)
7)
7)
9)
30)
0)
29)
27)
27)
31)
31)
e 0–2)
atheter
VR  pulmonary vascular resistance; Qp  pulmonary blood flow;
vena cava.
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September 18, 2012:1094–1102 Pre-Fontan CMR Versus Cath Evaluationare shown in Table 5. An example of CMR imaging in a
re-Fontan patient is shown in Figure 1. No differences
ere noted in qualitative ventricular shortening or AVVR
n echo between all 3 groups.
In comparing hemodynamics in cath patients, no differences
ere noted between CM and C in age at cath, body surface
rea, interventions, pressures in the SVC, PAs and the single
entricle, pulmonary and systemic vascular resistance, hemo-
lobin, systemic arterial O2 saturation, and ICU days. When
he number of patients with measured RPA and LPA pres-
ures were divided into groups with 15 or 16 mm Hg or
ivided into those with 12, 13 to 16, or 17 mm Hg, no
ignificant differences between CM and C were noted.
atients in C, however, were significantly closer to Fontan
ompletion than the CM group at the time of cath. Addi-
ionally, the CM group had statistically lower systemic (3.6
s. 4.1 l/min/m2) and pulmonary flows (2.3 vs. 2.6 l/min/m2)
compared with C. In patients who underwent cath, PVR
ranged from 1.54  0.52 Wood units to 1.63  0.61 Woods
nits and ventricular end-diastolic pressure ranged from
.08  4.32 mm Hg to 6.18  3.70 mm Hg. These
parameters were similar to the 3 patients in the CM group
CMR DataTable 5 CMR Data
CM
Age at CMR 2.61 0.9 (n
Years from CMR to Fontan 0.48 0.7 (n
Height, cm 86.7 8.9 (n
Weight, kg 12.7 2.1 (n
BSA at CMR, m2 0.57 0.08 (
Ejection fraction, % 64.0 7.7 (n
End-diastolic volume, cc/m2 85.7 15.5 (
CI, velocity mapping, l/min/m2 5.06 1.0 (n
Values are mean  SD.
BSA body surface area; CI cardiac index (flow out semilunar val
and echocardiography.
Clinical Outcome Across CohortsTable 6 Clinical Outcome Across Cohorts
CM
Number of patients, N 31*
Age at surgery, years 3.0 1.10
Extracardiac conduit, N 27
Lateral tunnel, N 4
Fenestrations, N 25
Total bypass time, min 72.7 22.5
Circulatory arrest time, min 26.1 6.58
Days in ICU 5.74 11.1
Other surgical procedures, N 2
Surgical complications, N 3
Interventions after Fontan, N 8
Incidence of pleural effusions, N 4
LOS, days 12.5 13.6
O2 Sat at discharge, % 85.3 4.21
Values are mean  SD. *6 patients did not undergo Fontan completi
(CMR) and cath for CMR accuracy.
LOS  length of stay; other abbreviations as in Table 4.ho are awaiting Fontan completion (for scheduling reasons).
Similarly, no differences between CM and MR groups
ere noted with regard to age at CMR, body surface area
nd measures of ventricular performance (ejection fraction,
nd-diastolic volume, and cardiac index). Similarly to the
ath comparison, patients in MR were closer to Fontan
ompletion than those in the CM group.
Ten decompressing vessels/left SVC were noted in the
M group while 4 each were noted in the C and MR
roups (p  0.052).
CLINICAL OUTCOME. Short-term surgical outcome and
hospital course are shown in Table 6 and demonstrates no
significant differences in any clinical outcome parameters
between MR, C, and CM. All patients who underwent
Fontan completion survived. All patients who had pleural
effusions underwent hospital stays of 20 days.
Diagnostic success and comparison between cath and
CMR. In the 37 CM patients, no discrepant anatomic
findings were noted between CMR and cath. No difference
at surgery was noted between CMR or cath with the
exception of LPA hypoplasia: 1 patient in CM (96%), 2 in
MR p Value
2.75 0.54 (n 41) 0.25
0.14 0.14 (n 41) 0.01
90.1 6.25 (n 41) 0.08
13.0 1.54 (n 41) 0.35
) 0.56 0.05 (n 41) 0.29
63.1 9.57 (n 38) 0.26
) 85.0 22.3 (n 38) 0.40
4.96 0.90 (n 39) 0.23
R cardiac magnetic resonance; MR cardiac magnetic resonance
CMR Only Cath Only p Value
41 41
2.89 0.54 2.79 0.64 0.38
33 25
8 16
37 39 0.68
67.1 14.3 66.7 16.1 0.27
27.1 8.59 24.1 6.88 0.23
3.02 1.72 3.78 6.76 0.26
3 8 0.17
4 5 0.94
5 3 0.06
4 4 0.96
9.78 5.80 12.2 13.5 0.51
86.2 3.99 86.1 3.51 0.28
are used only for comparison between cardiac magnetic resonance 30)
 30)
 30)
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preoperative finding of LPA hypoplasia underneath the
neoaortic arch and no PA arterioplasty was performed as is
the surgeon’s usual practice when LPA hypoplasia is iden-
tified (p  0.96 between groups). If the surgeon did not
perform a PA arterioplasty, the presumption is that he did
not feel the LPA was hypoplastic.
Linear measurements were compared between CMR and
cath in the CM group in the SVC, PAs, and aorta. Table 7
nd Figure 3 list the raw measurements and the Bland-
ltman plot (all structures included), respectively. No sig-
ificant differences between CMR and cath were noted with
he raw data; the Bland-Altman plot demonstrated a narrow
and between 2 standard deviations of approximately  1
m. Interobserver variability ranged from 2.3% to 5.6%
epending on the structure.
Linear Measurements in CMTable 7 Linear Measurements in CM
CMR Cath p Value
SVC, mm 9.62 1.74 9.50 1.60 0.12
RPA, mm 7.79 2.17 7.79 2.22 0.49
CPA, mm 6.58 2.46 6.75 2.29 0.06
LPA, mm 7.41 1.79 7.36 1.83 0.34
AAo, mm 19.3 4.11 19.4 4.23 0.18
Isthmus, mm 9.50 1.79 9.75 1.73 0.06
DAo, mm 9.29 1.66 9.19 1.57 0.14
Values are mean  SD.
AAo  ascending aorta; CPA  central pulmonary artery; DAo  descending aorta; other
bbreviations as in Table 4.
Figure 3 Bland-Altman Plot of CMR and Cath Linear Measurem
Note the narrow band between 2 SD (2) above and below the mean of approxima
vena cavae, branch pulmonary arteries, and aorta) are all included in this graph. Ciscussion
his study demonstrated that single ventricle patients not
equiring an intervention can undergo successful Fontan
ith CMR and echo evaluation alone with similar short-
erm outcomes to patients who underwent C as a control.
his study demonstrated comparability of preoperative de-
ographics and hemodynamics in each group which al-
owed for comparison between preoperative evaluation
trategies showing comparable preoperative risk. Differences
n ventricular morphology were not statistically significant;
ecent data has demonstrated that morphology has little
mpact on short-term outcome (23,24). The positive and
egative predictive values of echo and CMR to determine
ndings or interventions at cath were each 100%; when
MR is not used, positive and negative predictive values are
ower, especially the negative predictive value (our data in
he C group using echo alone is very similar to the original
o criteria findings). Cath and CMR are usually used in
ombination to assess aortopulmonary collaterals or to assess
he need for or evaluate the success of an intervention.
MR assessment of cardiovascular structures was accurate
hen compared with cath and surgical observation; the
iagnostic success rate was 95% when compared to
urgical observation with no quantitative difference between
MR and cath with regard to linear measurements or
tructures visualized. The addition of CMR on a routine
asis changed the Ro criteria in 55% avoiding the need for
ath and added additional information in another 27%. By
ividing the study population into 3 different groups, this
mm. All linear measurements (superior
cardiac catheterization; CMR  cardiac magnetic resonance.ents
tely 1
ath 
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preoperative investigations prior to Fontan.
There are no prior studies investigating the use of routine
CMR for preoperative evaluation prior to Fontan. With the
percentage of complete echos in our study ranging from
46% to 53% across groups, echo alone appears insufficient.
Cath is a common supplement for preoperative evaluation
and provides the benefit of immediate intervention if
required. CMR, however, provides an equally effective and
safer alternative for diagnosis.
Previous studies have investigated noninvasive preopera-
tive evaluations throughout the stages of single ventricle
reconstruction. As mentioned, Ro et al. (8) developed a set
of criteria to determine the need for cath prior to Fontan
based mainly on echo data, hemoglobin and pulse oximetry
(8). In that study, they suggested that CMR may have
helped and indeed, applying the Ro criteria in our patient
population changed the need for cath in 55%.
Two studies by Brown et al. (12,13) investigated the
utility of cath prior to bidirectional Glenn/hemi-Fontan, 1
retrospective (12) and 1 prospective (13). In their retrospec-
tive analysis, they demonstrated that unless echo indicated a
need, routine cath prior to surgery rarely provided new
information or resulted in an intervention. Echo, however,
was only 70% successful in completely characterizing pre-
operative patients and 73% successful at PA assessment.
The prospective study compared both CMR and cath prior
to bidirectional Glenn/hemi-Fontan and found CMR was
safer than cath and incurred less cost.
A proposed algorithm by Prakash et al. (25) suggested
dividing single ventricle patients who were to undergo
Fontan into a “high risk” and “low risk” group based on
certain criteria including history (respiratory or lung disor-
der, heterotaxy or genetic syndromes), echocardiography
(valve insufficiency, ventricular dysfunction, pulmonary vein
stenosis), or angiography (branch PA stenosis, pulmonary
vein stenosis, or systemic venous anomalies other than a left
SVC). They stated that the algorithm could effectively
screen patients unsuitable for Fontan and may be able to
determine which patients needed invasive preoperative test-
ing. The sensitivity and negative predictive values were
100%, however, the specificity and positive predictive values
were low (67% and 16%, respectively). All of the 3 cases in
our study that could not progress to Fontan because of death
or heart transplantation met criteria for a “high risk”
Fontan, unsuitable for that operation.
CMR is a safer, noninvasive test when compared with
cath, which has complications such as risk of bleeding, ICU
stays, prolonged hospitalization, and involves ionizing radi-
ation with cancer risk (9–11,26). Our study showed an
effective radiation dose of 6.8 mSv on average (range 2.1 to
27.9 mSv), falling into the range of other reported pediatric
cath studies (27,28). In the current study, there was only 1
complication in all patients undergoing CMR (1%) and 3
complications in all patients undergoing cath (4%) with
varying severity; endotracheal tube obstruction because ofsecretions in the CMR group versus complete heart block (1
with chest compressions and atropine) and inadvertent entry
into the right carotid artery in the cath group.
Study limitations. This study is retrospective and is subject
to all of the inherent biases that come with this type of
investigation. In particular, the decision to perform either a
cath or CMR prior to Fontan completion was the bias of the
clinical practice of the referring physician.
Statistically, some of the comparisons made were under-
powered, however, from a clinical standpoint, the differ-
ences between the groups were not significant (e.g., the
difference cardiopulmonary bypass time and circulatory
arrest time between C and MR groups on average, of 0.4
and 3 min, respectively, is not clinically significant enough
to warrant detection).
In addition, immediate surgical results and short-term
clinical outcomes were used to compare groups and no
intermediate or long-term follow-up was conducted.
Although immediate results are promising, a prospective,
randomized clinical trial is warranted to compare CMR
and cath prior to Fontan completion for diagnostic
success rates as well as short- and long-term clinical
outcomes.
Calculation of the average effective radiation dose was an
estimate and may not represent precise deposition of the
effective radiation dose.
Implications and Conclusions
Noninvasive imaging consisting of CMR and echo can
completely characterize the relevant information needed
prior to Fontan completion on a routine basis as well as need
for cath in select patients. CMR was able to accurately
assess cardiovascular anatomy and physiology compared
with cath and surgical observation. Because little difference
was noted between groups in preoperative hemodynamics or
anatomy, intraoperative surgical complications or immedi-
ate clinical outcome, a strong case may be made for
eliminating cath from routine preoperative evaluation. We
recommend that cath should be utilized if: 1) noninvasive
evaluation reveals need for potential interventions; 2) ven-
tricular function/hemodynamics appear poor on noninvasive
studies; 3) Ro criteria are met with CMR; 4) CMR is
contraindicated; or 5) noninvasive imaging methods cannot
obtain necessary information. Cath should not be required to
assess PVR or ventricular end-diastolic pressure routinely, as
our data demonstrated normal values. If poor ventricular
shortening is identified or if there is a clinical/imaging
suspicion of elevated PVR or ventricular end-diastolic
pressure, the patient should be directed to cath. Immediate
or long-term complications from cath should limit its use in
routine settings. The authors recognize that our institu-
tional bias is not to embolize aortopulmonary collaterals,
dilate stenotic branch pulmonary arteries, or arch abnormal-
ities prior to Fontan and this may change the decision-
1102 Fogel et al. JACC Vol. 60, No. 12, 2012
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to CM.
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